A Phase II Efficacy Study of MK-4827 in Patients With Mantle Cell Lymphoma.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 10 Nov 2016
At a glance
- Drugs Niraparib (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- Sponsors TESARO
- 24 Feb 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 29 Nov 2010 New trial record